Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development

Stefanie Scherer(Technical University of Munich), Dietmar Zehn(Technical University of Munich), Jacqueline Berner(Technical University of Munich), Lilian Aly(Technical University of Munich), Nils B. Becker(Université Claude Bernard Lyon 1), Ingo Kleiter(Dentsply Sirona (United States)), Kristiyan Kanev(Technical University of Munich), Ming Wu(University of Michigan–Ann Arbor), Thomas Höfer(Heidelberg University), Alessandro Greco(German Cancer Research Center), Martin Klingenspor(Weihenstephan-Triesdorf University of Applied Sciences), Christine Wurmser(Technical University of Munich), Valeria Fumagalli(Vita-Salute San Raffaele University), Hayley A. McNamara(Technical University of Munich), Lara V. Donhauser(Technical University of Munich), Talyn Chu(Technical University of Munich), Daniel J. Puleston(Bloomberg (United States)), Gustavo P. de Almeida(Technical University of Munich), Susanne Oberle(Sanofi (Switzerland)), Tamar Nizharadze(German Cancer Research Center), Madlaina von Hoesslin(Technical University of Munich), Erika L. Pearce(Bloomberg (United States)), Maria J. G. T. Vehreschild(Goethe University Frankfurt), Thomas Korn(TUM Klinikum), Christoph Mayer(Goethe University Frankfurt), Martin Prlic(University of Washington), Zeynep Esencan(Medpace (United States)), Percy A. Knolle(TUM Klinikum), Matteo Iannacone(Harvard University), Ann-Katrin Gerullis(Technical University of Munich), Francesc Baixauli(Department of Biomedicine Basel), Anna M. Schulz(Weihenstephan-Triesdorf University of Applied Sciences), Patrick Roelli(Nordregio)
Nature Immunology
February 16, 2023
Cited by 31


Related Papers